Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Identify essential line items for unexpected bills and set aside funds to smooth out financial shocks. A clear plan reduces anxiety and keeps spending in check.
15,931 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Two AI powerhouses, two very different bets. This guide compares Nvidia and Palantir to help you decide which path fi...
A growing chorus of advisors is championing a three-ETF approach as a simple, disciplined path to retirement wealth. ...
The U.S. retirement system gets c-plus in key metrics, prompting policymakers to push overdue reforms. This report ex...
Titan America (TTAM) is shaping investor expectations in 2026 as Q1 results roll in. This deep dive translates earnin...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Bakkt faces a pivotal year as crypto markets evolve and cash flow models mature. This guide explains what bakkt (bkkt...
A notable fund just built a sizable position in Appian as AI driven automation accelerates. This article breaks down ...
NuScale Power just reported earnings, and the market pushed the stock lower. This article explains why patient invest...
A mid-sized fund wrapped up a $9 million exit from a major pawn shop operator after a rally of about 150% over the ye...
An insider at Mirion Technologies reduced his stake by roughly $165,000 in a May 2026 move. This article explains how...
A growth stock has fallen over 40% in 2026, testing the patience of investors. This guide breaks down how to assess w...